full record print

PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases

author
statement of authorship
V.Z. Lankin, A.K. Tikhaze, M. Viigimaa, I.E. Chazova
source
Terapevticheskii Arkhiv
publisher
CJSC Consilium Medicum
journal volume number month
Vol. 90, 9
year of publication
pages
p. 27-30
url
ISSN
0040-3660
notes
Bibliogr.: 15 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
subject term
keyword
antioxidant enzymes
cholesterol-lowering drugs
inhibitor of PCSK9
oxidized low-density lipoproteins
category (general)
category (sub)
Lankin, V.Z., Tikhaze, A.K., Viigimaa, M., Chazova, I.Å. PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases // Terapevticheskii Arkhiv (2018) Vol. 90, 9, p. 27-30. https://doi.org/10.26442/terarkh201890927-30